Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
67,603
-11,576
-15% -$1.09M 0.02% 610
2026
Q1
$9.39M Sell
79,179
-12,339
-13% -$1.53M 0.05% 344
2025
Q4
$10.9M Sell
91,518
-5,915
-6% -$772K 0.06% 292
2025
Q3
$14.2M Sell
97,433
-4,741
-5% -$717K 0.09% 210
2025
Q2
$15.9M Buy
102,174
+38,788
+61% +$6.15M 0.12% 167
2025
Q1
$10.3M Sell
63,386
-8,130
-11% -$1.35M 0.11% 182
2024
Q4
$11.5M Buy
71,516
+9,419
+15% +$1.68M 0.14% 145
2024
Q3
$12.2M Buy
62,097
+30,217
+95% +$5.57M 0.24% 100
2024
Q2
$5.53M Buy
31,880
+29,568
+1,279% +$4.92M 0.24% 94
2024
Q1
$399K Buy
+2,312
New +$433K 0.05% 314

Other funds holding ZTS

&Partners's ZTS Position: Q2 2026 in Review

&Partners reduced its Zoetis (ZTS) stake by 15% in Q2 2026, selling an estimated $1.09M and leaving 67,603 shares worth $4.84M. The position accounts for 0.02% of the portfolio, ranked #610.

&Partners first reported a position in ZTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $15.9M in Q2 2025. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • &Partners held 67,603 shares of Zoetis worth $4.84M as of Q2 2026.
  • &Partners sold 11,576 Zoetis shares in Q2 2026, an estimated $1.09M.
  • Zoetis made up 0.02% of &Partners's portfolio in Q2 2026, its #610 holding.
  • &Partners first reported a position in Zoetis in Q1 2024 and has held it in 10 quarters since.
  • &Partners's Zoetis position peaked at $15.9M in Q2 2025.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.